𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome

✍ Scribed by Federico P. Gómez; Graciela Martínez-Pallí; Joan A. Barberà; Josep Roca; Miquel Navasa; Robert Rodríguez-Roisin


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
176 KB
Volume
40
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The mechanism of orthodeoxia (OD), or decreased partial pressure of arterial oxygen (PaO 2 ) from supine to upright, a characteristic feature of hepatopulmonary syndrome (HPS), has never been comprehensively elucidated. We therefore investigated the intrapulmonary (shunt and ventilation-perfusion [V ˙A/Q ˙] mismatching) and extrapulmonary factors governing PaO 2 in 20 patients with mild to severe HPS (14 males, 6 females; 50 ؎ 3 years old SE) at upright and supine, in random order. We set out a cutoff value for OD, namely a PaO 2 decrease >5% or >4 mm Hg (area under the receiver operating characteristic curve, 0.96 each). Compared to supine, 5 patients showed OD (PaO 2 change, ؊11% ؎ 2%, ؊7 ؎ 1 mm Hg, P < .05) with further V ˙A/Q ˙worsening (shunt ؉ low V ˙A/Q ˙mode increased from 19% ؎ 7% to 21% ؎ 7% of cardiac output [Q ˙T], P < .05), as opposed to 15 patients who did not (؉2% ؎ 2%, ؉1؎ 1 mm Hg) with V ˙A/Q ˙improvement (from 20% ؎ 4% to 16% ؎ 4% of Q ˙T, P < .01). Cardiac output was significantly lower in OD patients in both positions. Changes in extrapulmonary factors at upright, such as increased minute ventilation and decreased Q ˙T, were of similar magnitude in both subsets of patients. In conclusion, our data suggest that gas exchange response to OD in HPS points to a more altered pulmonary vascular tone inducing heterogeneous blood flow redistribution to lung zones with prominent intrapulmonary vascular dilatations. (HEPATOLOGY 2004;40:660 -666.) Abbreviations: HPS, hepatopulmonary syndrome; OD, orthodexia; PaO 2 ; partial pressure of arterial oxygen; Pv O 2, partial pressure of mixed venous oxygen; FEV, forced expiratory volume in one second.


📜 SIMILAR VOLUMES


Pilot study of pentoxifylline in hepatop
✍ Rajasekhar Tanikella; George M. Philips; Dorothy K. Faulk; Steven M. Kawut; Mich 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Hepatopulmonary syndrome (HPS) results when chronic liver disease or portal hypertension causes intrapulmonary microvascular dilatation with hypoxemia. In experimental HPS, tumor necrosis factor alpha (TNF-␣) overproduction contributes to vasodilatation, which is improved by pentoxifylline, a TNF-␣

Improvement in hepatopulmonary syndrome
✍ Edmund M. T. Lau; Geoffrey McCaughan; Paul J. Torzillo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Spontaneous resolution of hepatopulmonary syndrome (HPS) without liver transplantation or improvement in the underlying liver disease has rarely been reported in the literature. Increased endogenous production of nitric oxide has been implicated in the pathogenesis of HPS. We report the case of a 50

Cost-effectiveness of screening for hepa
✍ D. Neil Roberts; Miguel R. Arguedas; Michael B. Fallon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

The hepatopulmonary syndrome (HPS) is present in 15-20% of patients with cirrhosis undergoing orthotopic liver transplantation (OLT) evaluation. Both preoperative and post-OLT mortality is increased in HPS patients particularly when hypoxemia is severe. Screening for HPS could enhance detection of O